Episodes
-
Canadian dermatologist Dr. Ronald B. Vender discusses topical methotrexate, systemic medications in pediatric patients, and depression.
-
Missing episodes?
-
Canadian dermatologist Dr. Ronald B. Vender discusses comorbid obesity, the effect of smoking on psoriasis, and apremilast in real world studies.
-
Canadian dermatologist Dr. Ronald B. Vender discusses PASI thresholds, migraines, and the importance of topical treatment application feel to a patient.
-
Canadian dermatologist Dr. Ronald B. Vender talks about paradoxical eczema in psoriasis patients on biologics, real-world blood screening, and patient satisfaction for brodalumab.
-
Canadian dermatologist Dr. Ronald B. Vender talks about acitretin-methotrexate therapy in pediatric patients, psoriasis flares from systemic steroids, and adalimumab with methotrexate versus adalimumab mono therapy.
-
Canadian dermatologist Dr. Ronald B. Vender talks about treating psoriasis with teledermatology during the pandemic, air pollution triggering psoriasis flares, and ixekizumab response in pediatric plaque psoriasis patients.
-
Canadian dermatologist Dr. Ronald B. Vender talks about a link between psoriasis and non-alcoholic fatty liver disease, vaccine hesitancy in psoriasis patients, and bimekizumab safety profiles.
-
Canadian dermatologist Dr. Ronald B. Vender talks about psoriasis treatment efficacy in body regions, use of analgesics, and lifestyle factors and genetic risks of incident psoriasis.
-
Canadian dermatologist Dr. Ronald B. Vender talks about self-help for psoriasis patients, generalized pustular psoriasis and the link between early response and long-term response in psoriasis treatment.
-
Canadian dermatologist Dr. Ronald B. Vender talks about biologics use, biosimilars and the potential risk of incident venous thromboembolism and peripheral vascular disease in psoriasis.
-
Canadian dermatologist Dr. Vender talks about treating patients with ustekinumab withdrawal, combination therapy for plaque psoriasis and the potential link between chronic kidney disease and psoriasis.
-
Canadian dermatologist Dr. Vender talks about the effect of alcohol on treatment response, biologic fatigue and treatment changes in biologics.
-
Canadian dermatologist Dr. Vender talks about biologic treatment safety during Covid-19, the effect of intermittent fasting on psoriasis and five-year data on using tildrakizumab to treat psoriasis patients.
-
Canadian dermatologist Dr. Vender talks about treatment efficacy using PASI scores, using botox for plaque psoriasis and the independent mortality risk associated with psoriasis.
-
Coming soon to wherever you get your podcasts.
